DNA topoisomerases: topoisomerase- targeting drugs
Gespeichert in:
| Format: | Buch |
|---|---|
| Sprache: | English |
| Veröffentlicht: |
San Diego [u.a.]
Acad. Press
1994
|
| Schriftenreihe: | Advances in pharmacology
29,B |
| Schlagworte: | |
| Beschreibung: | Einzelaufnahme eines Zeitschr.-Bd. |
| Beschreibung: | XVII, 315 S. Ill., graph. Darst. |
| ISBN: | 0120329301 |
Internformat
MARC
| LEADER | 00000nam a2200000 cb4500 | ||
|---|---|---|---|
| 001 | BV009902330 | ||
| 003 | DE-604 | ||
| 005 | 20210412 | ||
| 007 | t | ||
| 008 | 941117s1994 ad|| |||| 00||| engod | ||
| 020 | |a 0120329301 |9 0-12-032930-1 | ||
| 035 | |a (OCoLC)31619613 | ||
| 035 | |a (DE-599)BVBBV009902330 | ||
| 040 | |a DE-604 |b ger |e rakwb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-355 |a DE-12 |a DE-20 |a DE-19 |a DE-11 | ||
| 050 | 0 | |a QP616.D56 | |
| 084 | |a WG 1700 |0 (DE-625)148495: |2 rvk | ||
| 245 | 1 | 0 | |a DNA topoisomerases |b topoisomerase- targeting drugs |c ed. by Leroy F. Liu |
| 264 | 1 | |a San Diego [u.a.] |b Acad. Press |c 1994 | |
| 300 | |a XVII, 315 S. |b Ill., graph. Darst. | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 490 | 0 | |a Advances in pharmacology |v 29,B | |
| 500 | |a Einzelaufnahme eines Zeitschr.-Bd. | ||
| 650 | 7 | |a Cancer - Chimiothérapie |2 ram | |
| 650 | 2 | |a DNA topoisomerases type I | |
| 650 | 2 | |a DNA topoisomerases type II | |
| 650 | 2 | |a Pharmacologie | |
| 650 | 2 | |a Tumeurs - Traitement médicamenteux | |
| 650 | 4 | |a Cancer |x Chemotherapy | |
| 650 | 4 | |a DNA Topoisomerases, Type I | |
| 650 | 4 | |a DNA Topoisomerases, Type II | |
| 650 | 4 | |a DNA topoisomerase I | |
| 650 | 4 | |a DNA topoisomerase II | |
| 650 | 4 | |a Neoplasms |x drug therapy | |
| 650 | 0 | 7 | |a Arzneistoffträger |0 (DE-588)4278196-6 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Molekularbiologie |0 (DE-588)4039983-7 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a DNS-Topoisomerase I |0 (DE-588)4198585-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a DNS-Topoisomerasen |0 (DE-588)4333298-5 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Pharmakologie |0 (DE-588)4045687-0 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a DNS-Topoisomerase I |0 (DE-588)4198585-0 |D s |
| 689 | 0 | 1 | |a Pharmakologie |0 (DE-588)4045687-0 |D s |
| 689 | 0 | |5 DE-604 | |
| 689 | 1 | 0 | |a DNS-Topoisomerase I |0 (DE-588)4198585-0 |D s |
| 689 | 1 | 1 | |a Molekularbiologie |0 (DE-588)4039983-7 |D s |
| 689 | 1 | |5 DE-604 | |
| 689 | 2 | 0 | |a DNS-Topoisomerase I |0 (DE-588)4198585-0 |D s |
| 689 | 2 | 1 | |a Arzneistoffträger |0 (DE-588)4278196-6 |D s |
| 689 | 2 | |5 DE-604 | |
| 689 | 3 | 0 | |a DNS-Topoisomerasen |0 (DE-588)4333298-5 |D s |
| 689 | 3 | |8 1\p |5 DE-604 | |
| 700 | 1 | |a Liu, Leroy F. |e Sonstige |4 oth | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-006557719 | ||
| 883 | 1 | |8 1\p |a cgwrk |d 20201028 |q DE-101 |u https://d-nb.info/provenance/plan#cgwrk | |
Datensatz im Suchindex
| _version_ | 1804124263310950400 |
|---|---|
| any_adam_object | |
| building | Verbundindex |
| bvnumber | BV009902330 |
| callnumber-first | Q - Science |
| callnumber-label | QP616 |
| callnumber-raw | QP616.D56 |
| callnumber-search | QP616.D56 |
| callnumber-sort | QP 3616 D56 |
| callnumber-subject | QP - Physiology |
| classification_rvk | WG 1700 |
| ctrlnum | (OCoLC)31619613 (DE-599)BVBBV009902330 |
| discipline | Biologie |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02366nam a2200649 cb4500</leader><controlfield tag="001">BV009902330</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">20210412 </controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">941117s1994 ad|| |||| 00||| engod</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0120329301</subfield><subfield code="9">0-12-032930-1</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)31619613</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV009902330</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-355</subfield><subfield code="a">DE-12</subfield><subfield code="a">DE-20</subfield><subfield code="a">DE-19</subfield><subfield code="a">DE-11</subfield></datafield><datafield tag="050" ind1=" " ind2="0"><subfield code="a">QP616.D56</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">WG 1700</subfield><subfield code="0">(DE-625)148495:</subfield><subfield code="2">rvk</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">DNA topoisomerases</subfield><subfield code="b">topoisomerase- targeting drugs</subfield><subfield code="c">ed. by Leroy F. Liu</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">San Diego [u.a.]</subfield><subfield code="b">Acad. Press</subfield><subfield code="c">1994</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVII, 315 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Advances in pharmacology</subfield><subfield code="v">29,B</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Einzelaufnahme eines Zeitschr.-Bd.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer - Chimiothérapie</subfield><subfield code="2">ram</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">DNA topoisomerases type I</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">DNA topoisomerases type II</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Pharmacologie</subfield></datafield><datafield tag="650" ind1=" " ind2="2"><subfield code="a">Tumeurs - Traitement médicamenteux</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA Topoisomerases, Type I</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA Topoisomerases, Type II</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA topoisomerase I</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">DNA topoisomerase II</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms</subfield><subfield code="x">drug therapy</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Molekularbiologie</subfield><subfield code="0">(DE-588)4039983-7</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">DNS-Topoisomerase I</subfield><subfield code="0">(DE-588)4198585-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">DNS-Topoisomerasen</subfield><subfield code="0">(DE-588)4333298-5</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">DNS-Topoisomerase I</subfield><subfield code="0">(DE-588)4198585-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Pharmakologie</subfield><subfield code="0">(DE-588)4045687-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="1" ind2="0"><subfield code="a">DNS-Topoisomerase I</subfield><subfield code="0">(DE-588)4198585-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2="1"><subfield code="a">Molekularbiologie</subfield><subfield code="0">(DE-588)4039983-7</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="1" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="2" ind2="0"><subfield code="a">DNS-Topoisomerase I</subfield><subfield code="0">(DE-588)4198585-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2="1"><subfield code="a">Arzneistoffträger</subfield><subfield code="0">(DE-588)4278196-6</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="2" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="689" ind1="3" ind2="0"><subfield code="a">DNS-Topoisomerasen</subfield><subfield code="0">(DE-588)4333298-5</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="3" ind2=" "><subfield code="8">1\p</subfield><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Liu, Leroy F.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-006557719</subfield></datafield><datafield tag="883" ind1="1" ind2=" "><subfield code="8">1\p</subfield><subfield code="a">cgwrk</subfield><subfield code="d">20201028</subfield><subfield code="q">DE-101</subfield><subfield code="u">https://d-nb.info/provenance/plan#cgwrk</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV009902330 |
| illustrated | Illustrated |
| indexdate | 2024-07-09T17:42:53Z |
| institution | BVB |
| isbn | 0120329301 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-006557719 |
| oclc_num | 31619613 |
| open_access_boolean | |
| owner | DE-355 DE-BY-UBR DE-12 DE-20 DE-19 DE-BY-UBM DE-11 |
| owner_facet | DE-355 DE-BY-UBR DE-12 DE-20 DE-19 DE-BY-UBM DE-11 |
| physical | XVII, 315 S. Ill., graph. Darst. |
| publishDate | 1994 |
| publishDateSearch | 1994 |
| publishDateSort | 1994 |
| publisher | Acad. Press |
| record_format | marc |
| series2 | Advances in pharmacology |
| spelling | DNA topoisomerases topoisomerase- targeting drugs ed. by Leroy F. Liu San Diego [u.a.] Acad. Press 1994 XVII, 315 S. Ill., graph. Darst. txt rdacontent n rdamedia nc rdacarrier Advances in pharmacology 29,B Einzelaufnahme eines Zeitschr.-Bd. Cancer - Chimiothérapie ram DNA topoisomerases type I DNA topoisomerases type II Pharmacologie Tumeurs - Traitement médicamenteux Cancer Chemotherapy DNA Topoisomerases, Type I DNA Topoisomerases, Type II DNA topoisomerase I DNA topoisomerase II Neoplasms drug therapy Arzneistoffträger (DE-588)4278196-6 gnd rswk-swf Molekularbiologie (DE-588)4039983-7 gnd rswk-swf DNS-Topoisomerase I (DE-588)4198585-0 gnd rswk-swf DNS-Topoisomerasen (DE-588)4333298-5 gnd rswk-swf Pharmakologie (DE-588)4045687-0 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content DNS-Topoisomerase I (DE-588)4198585-0 s Pharmakologie (DE-588)4045687-0 s DE-604 Molekularbiologie (DE-588)4039983-7 s Arzneistoffträger (DE-588)4278196-6 s DNS-Topoisomerasen (DE-588)4333298-5 s 1\p DE-604 Liu, Leroy F. Sonstige oth 1\p cgwrk 20201028 DE-101 https://d-nb.info/provenance/plan#cgwrk |
| spellingShingle | DNA topoisomerases topoisomerase- targeting drugs Cancer - Chimiothérapie ram DNA topoisomerases type I DNA topoisomerases type II Pharmacologie Tumeurs - Traitement médicamenteux Cancer Chemotherapy DNA Topoisomerases, Type I DNA Topoisomerases, Type II DNA topoisomerase I DNA topoisomerase II Neoplasms drug therapy Arzneistoffträger (DE-588)4278196-6 gnd Molekularbiologie (DE-588)4039983-7 gnd DNS-Topoisomerase I (DE-588)4198585-0 gnd DNS-Topoisomerasen (DE-588)4333298-5 gnd Pharmakologie (DE-588)4045687-0 gnd |
| subject_GND | (DE-588)4278196-6 (DE-588)4039983-7 (DE-588)4198585-0 (DE-588)4333298-5 (DE-588)4045687-0 (DE-588)4143413-4 |
| title | DNA topoisomerases topoisomerase- targeting drugs |
| title_auth | DNA topoisomerases topoisomerase- targeting drugs |
| title_exact_search | DNA topoisomerases topoisomerase- targeting drugs |
| title_full | DNA topoisomerases topoisomerase- targeting drugs ed. by Leroy F. Liu |
| title_fullStr | DNA topoisomerases topoisomerase- targeting drugs ed. by Leroy F. Liu |
| title_full_unstemmed | DNA topoisomerases topoisomerase- targeting drugs ed. by Leroy F. Liu |
| title_short | DNA topoisomerases |
| title_sort | dna topoisomerases topoisomerase targeting drugs |
| title_sub | topoisomerase- targeting drugs |
| topic | Cancer - Chimiothérapie ram DNA topoisomerases type I DNA topoisomerases type II Pharmacologie Tumeurs - Traitement médicamenteux Cancer Chemotherapy DNA Topoisomerases, Type I DNA Topoisomerases, Type II DNA topoisomerase I DNA topoisomerase II Neoplasms drug therapy Arzneistoffträger (DE-588)4278196-6 gnd Molekularbiologie (DE-588)4039983-7 gnd DNS-Topoisomerase I (DE-588)4198585-0 gnd DNS-Topoisomerasen (DE-588)4333298-5 gnd Pharmakologie (DE-588)4045687-0 gnd |
| topic_facet | Cancer - Chimiothérapie DNA topoisomerases type I DNA topoisomerases type II Pharmacologie Tumeurs - Traitement médicamenteux Cancer Chemotherapy DNA Topoisomerases, Type I DNA Topoisomerases, Type II DNA topoisomerase I DNA topoisomerase II Neoplasms drug therapy Arzneistoffträger Molekularbiologie DNS-Topoisomerase I DNS-Topoisomerasen Pharmakologie Aufsatzsammlung |
| work_keys_str_mv | AT liuleroyf dnatopoisomerasestopoisomerasetargetingdrugs |